Tag: Biologic therapy

During clinical trials for plaque psoriasis, infections occurred in 36% of patients treated with Bimzelx compared to 23% in the placebo group through 16 weeks. Understanding **how safe is Bimzelx?** involves evaluating its full safety profile, which includes both common and rare but serious adverse reactions.

Fatigue is one of the most prevalent and debilitating symptoms reported by patients with chronic inflammatory diseases, affecting between 40-70% of those with conditions like ankylosing spondylitis and psoriatic arthritis. Research confirms that **Taltz**, which targets inflammation, can significantly help with fatigue associated with these conditions by addressing the root cause of the exhaustion.

Globally, the demand for plasma-derived therapies is steadily increasing, with some regions experiencing growth rates of 8–9% per year prior to the COVID-19 pandemic. These life-saving treatments, known as plasma-derived medicines, are crucial for patients with a variety of chronic, rare, and complex diseases.

Systemic lupus erythematosus (SLE) affects an estimated 204,295 people in the United States. When considering treatment, a key question is: **Is Saphnelo stronger than Benlysta?** While they are generally comparable, their strengths differ based on the patient's specific lupus symptoms and profile.

According to the American Thyroid Association, Tepezza (teprotumumab) is not a chemotherapy drug but a targeted biologic therapy for an autoimmune condition known as Thyroid Eye Disease (TED). The misconception about whether is tepezza a form of chemotherapy? often arises due to its intravenous administration and potential side effects, but its mechanism of action is entirely distinct from the non-specific, cytotoxic effects of cancer-fighting agents.

Clinical studies have shown risankizumab to be safe and effective for continuous use in treating chronic conditions like psoriasis for up to 6 years. Understanding **how long can you take risankizumab?** involves reviewing clinical trial data, real-world experience, and discussing a long-term treatment plan with a healthcare provider.

While Dupixent is commonly prescribed for long-term use in chronic inflammatory conditions, a 2023 study found that over 80% of patients with atopic dermatitis who attempted a supervised tapering schedule were successful in reducing their dose frequency. This offers hope for those wondering if they can ever get off of Dupixent.

According to the American College of Rheumatology, rituximab is a drug used to treat rheumatoid arthritis that has not improved with other medications. It is a biologic that offers a different approach to managing disease activity, especially in patients with moderate to severe active disease who have not responded adequately to TNF antagonists.

Behçet's disease, a rare inflammatory disorder, has a global prevalence estimated at 10.3 per 100,000 people [1.7.6]. Answering 'What is the drug of choice for Behçet's disease?' is complex, as no single medication is universally effective; treatment is tailored to the specific organ systems involved and symptom severity [1.3.3].

Amgevita (adalimumab) lowers the body's ability to fight infections [1.6.7]. Knowing **what to avoid when taking Amgevita** is crucial for your safety and treatment effectiveness. This includes certain vaccines, medications, and discussing pre-existing health conditions with your doctor.